天弘国证生物医药ETF(159859)资产配置 |
|
|
| 报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
| 2023/9/30 |
3,305,200,000 |
- |
3,326,440,000 |
3,309,880,000 |
100% |
| 2023/6/30 |
2,915,080,000 |
- |
2,924,700,000 |
2,919,780,000 |
100% |
| 2023/3/31 |
1,809,930,000 |
- |
1,840,530,000 |
1,816,000,000 |
100% |
| 2022/12/31 |
1,473,580,000 |
- |
1,487,480,000 |
1,477,310,000 |
100% |
| 2022/9/30 |
1,443,170,000 |
- |
1,450,290,000 |
1,446,250,000 |
100% |
| 2022/6/30 |
1,246,750,000 |
- |
1,253,320,000 |
1,246,910,000 |
100% |
| 2022/3/31 |
1,100,280,000 |
- |
1,105,280,000 |
1,104,320,000 |
100% |
| 2021/12/31 |
1,195,860,000 |
- |
1,206,050,000 |
1,202,840,000 |
99% |
| 2021/9/30 |
146,428,000 |
- |
147,711,000 |
147,489,000 |
99% |
| 2021/6/30 |
23,742,200 |
- |
252,851,000 |
229,141,000 |
10% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
